MX378890B - Bifidobacterium longum ncimb 41715 para usarse en el tratamiento de obesidad y trastornos metabólicos asociados. - Google Patents
Bifidobacterium longum ncimb 41715 para usarse en el tratamiento de obesidad y trastornos metabólicos asociados.Info
- Publication number
- MX378890B MX378890B MX2018006905A MX2018006905A MX378890B MX 378890 B MX378890 B MX 378890B MX 2018006905 A MX2018006905 A MX 2018006905A MX 2018006905 A MX2018006905 A MX 2018006905A MX 378890 B MX378890 B MX 378890B
- Authority
- MX
- Mexico
- Prior art keywords
- obesity
- treatment
- bifidobacterium longum
- metabolic disorders
- associated metabolic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
- A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Child & Adolescent Psychology (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15199660 | 2015-12-11 | ||
| PCT/EP2016/080454 WO2017097987A1 (en) | 2015-12-11 | 2016-12-09 | Bifidobacterium longum for treating obesity and associated metabolic disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018006905A MX2018006905A (es) | 2018-08-24 |
| MX378890B true MX378890B (es) | 2025-03-10 |
Family
ID=55070675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018006905A MX378890B (es) | 2015-12-11 | 2016-12-09 | Bifidobacterium longum ncimb 41715 para usarse en el tratamiento de obesidad y trastornos metabólicos asociados. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10973862B2 (enExample) |
| EP (1) | EP3386523B1 (enExample) |
| JP (1) | JP6843140B2 (enExample) |
| KR (1) | KR102819885B1 (enExample) |
| CN (1) | CN109069552B (enExample) |
| AU (1) | AU2016368527B2 (enExample) |
| BR (1) | BR112018011665A2 (enExample) |
| CA (1) | CA3006176C (enExample) |
| DK (1) | DK3386523T3 (enExample) |
| ES (1) | ES2760076T3 (enExample) |
| MX (1) | MX378890B (enExample) |
| PL (1) | PL3386523T3 (enExample) |
| RU (1) | RU2740096C2 (enExample) |
| WO (1) | WO2017097987A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201703395PA (en) | 2014-10-31 | 2017-05-30 | Whole Biome Inc | Methods and compositions relating to microbial treatment and diagnosis of disorders |
| EP3589726A1 (en) | 2017-02-28 | 2020-01-08 | Alimentary Health Limited | Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection |
| CA3073615A1 (en) | 2017-08-25 | 2019-02-28 | University College Cork - National University Of Ireland Cork | Bifidobacterium longum for treating obesity and weight management |
| JP2020532515A (ja) | 2017-08-30 | 2020-11-12 | ペンデュラム セラピューティクス， インコーポレイテッド | マイクロバイオーム関連障害の処置のための方法および組成物 |
| WO2019199094A1 (ko) * | 2018-04-11 | 2019-10-17 | 한국생명공학연구원 | 비만의 예방 또는 치료 효과를 가지는 신규 비피도박테리움 롱검 균주 또는 락토바실러스 람노서스 균주 및 이의 용도 |
| EP3823651A4 (en) | 2018-07-19 | 2022-04-27 | Pendulum Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR MICROBIAL TRANSPLANTATION |
| KR102224072B1 (ko) * | 2019-08-19 | 2021-03-10 | 주식회사 빙그레 | 면역 조절능력과 혈중콜레스테롤 감소 능력이 모두 뛰어난 비피도박테리엄 롱검 아종 균주 및 이의 용도 |
| WO2021180973A1 (en) | 2020-03-13 | 2021-09-16 | Precisionbiotics Group Limited | Bifidobacterium longum |
| CN113564069B (zh) * | 2021-05-28 | 2023-09-29 | 中山大学 | 一种长双歧杆菌、长双歧杆菌胞外多糖及其提取方法和应用 |
| CN115466689B (zh) * | 2022-02-09 | 2023-06-16 | 中国科学技术大学 | 用于预防和/或治疗代谢类疾病的益生菌组合物及其应用 |
| BG67720B1 (bg) * | 2022-03-18 | 2025-04-30 | "Ел Би Булгарикум" ЕАД | Щам bifidobacterium longum ssp. longum и бифидобактериален препарат с хиполипидемичен ефект, противовъзпалителен имуномодулиращ ефект и с намаляващ инсулиновата резистентност ефект |
| CN115637237B (zh) * | 2022-09-07 | 2024-09-17 | 辽宁贝克瑞生物科技有限公司 | 一株长双歧杆菌及其应用 |
| KR102789455B1 (ko) * | 2025-02-05 | 2025-04-04 | 주식회사 리스큐어바이오사이언시스 | 체지방 저감, 혈당 개선 및 근육 기능 강화 활성이 우수한 비피도박테리움 롱검 아종 롱검 lbmb322020 균주 및 이를 포함하는 대사성 질환 예방, 개선 또는 치료용 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8557233B2 (en) | 2007-03-28 | 2013-10-15 | Alimentary Heath Limited | Probiotic bifidobacterium strains |
| EP1974734A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics for reduction of risk of obesity |
| BRPI0811451A2 (pt) * | 2007-05-04 | 2014-11-04 | Alimentary Health Ltd | Exopolissacarídeo |
| MX339907B (es) * | 2008-11-11 | 2016-06-14 | Alimentary Health Ltd | Bifidobacterium longum. |
| EP2308499A1 (en) * | 2009-09-30 | 2011-04-13 | Nestec S.A. | Bifidobacterium longum ATCC BAA-999 (BL999) and weight control |
| EP2498789B1 (en) * | 2009-11-11 | 2016-06-22 | Alimentary Health Limited | Probiotic bifidobacterium strain |
| JP6286434B2 (ja) * | 2012-09-20 | 2018-02-28 | プロセラ インコーポレイテッド | 肥満および肥満関連疾患の治療のためのプロバイオティクス組成物および方法 |
-
2016
- 2016-12-09 DK DK16820183.8T patent/DK3386523T3/da active
- 2016-12-09 CA CA3006176A patent/CA3006176C/en active Active
- 2016-12-09 ES ES16820183T patent/ES2760076T3/es active Active
- 2016-12-09 US US16/060,765 patent/US10973862B2/en active Active
- 2016-12-09 KR KR1020187016182A patent/KR102819885B1/ko active Active
- 2016-12-09 RU RU2018119287A patent/RU2740096C2/ru active
- 2016-12-09 PL PL16820183T patent/PL3386523T3/pl unknown
- 2016-12-09 BR BR112018011665A patent/BR112018011665A2/pt not_active Application Discontinuation
- 2016-12-09 CN CN201680079991.4A patent/CN109069552B/zh active Active
- 2016-12-09 JP JP2018530515A patent/JP6843140B2/ja active Active
- 2016-12-09 EP EP16820183.8A patent/EP3386523B1/en active Active
- 2016-12-09 AU AU2016368527A patent/AU2016368527B2/en active Active
- 2016-12-09 MX MX2018006905A patent/MX378890B/es unknown
- 2016-12-09 WO PCT/EP2016/080454 patent/WO2017097987A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017097987A1 (en) | 2017-06-15 |
| RU2018119287A (ru) | 2020-01-13 |
| DK3386523T3 (da) | 2020-01-06 |
| EP3386523B1 (en) | 2019-10-09 |
| ES2760076T3 (es) | 2020-05-13 |
| PL3386523T3 (pl) | 2020-03-31 |
| MX2018006905A (es) | 2018-08-24 |
| KR20180083352A (ko) | 2018-07-20 |
| CA3006176A1 (en) | 2017-06-15 |
| RU2018119287A3 (enExample) | 2020-06-30 |
| AU2016368527A1 (en) | 2018-07-12 |
| KR102819885B1 (ko) | 2025-06-12 |
| RU2740096C2 (ru) | 2021-01-11 |
| JP2018536427A (ja) | 2018-12-13 |
| EP3386523A1 (en) | 2018-10-17 |
| US20190111090A1 (en) | 2019-04-18 |
| AU2016368527B2 (en) | 2023-01-12 |
| CN109069552A (zh) | 2018-12-21 |
| JP6843140B2 (ja) | 2021-03-17 |
| CA3006176C (en) | 2023-10-31 |
| US10973862B2 (en) | 2021-04-13 |
| CN109069552B (zh) | 2023-01-24 |
| BR112018011665A2 (pt) | 2018-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX378890B (es) | Bifidobacterium longum ncimb 41715 para usarse en el tratamiento de obesidad y trastornos metabólicos asociados. | |
| CY1122344T1 (el) | Blautia stercosis και wexlerae για χρηση στην θεραπευτικη αγωγη φλεγμονωδων και αυτοανοσων νοσων | |
| IL291445A (en) | Bacterial strains, their compositions and their use for the treatment of gastrointestinal disorders | |
| DK3858977T5 (da) | Stamme til forebyggelse og behandling af stofskiftesygdomme, og brugen heraf | |
| CY1122867T1 (el) | Συνθεσεις που περιλαμβανουν ενα βακτηριακο στελεχος του blautia hydrogenotrophica για χρηση στην θεραπεια ή προληψη διαρροιας ή δυσκοιλιοτητας | |
| WO2016086209A8 (en) | Probiotic and prebiotic compositions, and methods of use thereof for treatment of gastrointestinal disorders | |
| EA201990566A1 (ru) | Композиции, содержащие бактериальные штаммы | |
| DK3485010T3 (da) | Bacillus cibi-dnase-varianter og anvendelser deraf | |
| DK3668972T3 (da) | Konstruerede dnase-enzymer og anvendelse i terapi | |
| MX2016014807A (es) | Singenes de alfa(1,2)fucosiltransferasa para su utilizacion en la produccion de oligosacaridos fucosilados. | |
| MX395076B (es) | COMPOSICIÓN A BASE DE UN EXTRACTO DE BIOACTIVO DE L. fermentum PARA USARSE EN EL TRATAMIENTO DE CONDICIONES DERMATOLOGICAS HUMANAS. | |
| MX2021010886A (es) | Uso de medicamentos para disminuir la evolucion de la enfermedad de parkinson. | |
| MX2017000776A (es) | Polipeptidos fhbp meningococicos modificados. | |
| BR112016023752A2 (pt) | utilização de lactobacillus rhamnosus para promover a recuperação da diversidade da microbiota intestinal após disbiose | |
| MX383749B (es) | Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas | |
| EP3141254A4 (en) | Lactobacillus rhamnosus rht-3201 conjugated to polysaccharide polymer binder, and use thereof for prevention or treatment of atopic diseases | |
| DK3444010T3 (da) | Pklr-inhibering i behandlingen af nafld og hcc | |
| MX2017005249A (es) | Compuestos para usarse en el tratamiento antihelmintico. | |
| MX2020001632A (es) | Composiciones que comprenden cepas bacterianas. | |
| GB201600975D0 (en) | Novel strain of probiotic bacteria and compositions and uses thereof | |
| IL250450A0 (en) | A new Bacillus type bacterium and its uses | |
| EP3601525C0 (en) | LACTOBACILLUS CASEI PROBIOTIC STRAIN AND ITS USES | |
| MX2017001047A (es) | Compuestos para usar en el tratamiento antihelmintico. | |
| MX383473B (es) | Empleo de probióticos en el incremento de la fertilidad masculina. | |
| PL3197280T3 (pl) | Nowe szczepy bakterii gatunku bacillus amyloliquefaciens i powiązane zastosowania |